<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Johnson &amp; Johnson 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=29382></link><description><![CDATA[Johnson &amp; Johnson 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Sat, 11 Apr 2026 19:58:17 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2022/09/12_31017998_20220929132950_9801354464.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company]]></title><link>https://www.newswire.co.kr/newsRead.php?no=952408</link><description><![CDATA[NEW BRUNSWICK, N. J.--(Business Wire/Korea Newswire)--Johnson &amp; Johnson (the “Company”) (NYSE: JNJ) today took another step forward in establishing two independent, market-leading companies with the announcement of Kenvue as the name for the planned New Consumer Health Company. The new corporate brand comes to life through a compelling purpose, and a timeless visual brand.  Kenvue (pronounced k...]]></description><image><url><![CDATA[https://file.newswire.co.kr/data/datafile2/thumb/2022/09/31017998_20220929132756_7093732374.jpg]]></url></image><pubDate>Thu, 29 Sep 2022 13:43:36 +0900</pubDate></item><item><title><![CDATA[Johnson & Johnson Announces Encouraging First-in-Human Clinical Data for Investigational HIV Preventive Vaccine]]></title><link>https://www.newswire.co.kr/newsRead.php?no=853585</link><description><![CDATA[PARIS, France--(Business Wire/Korea Newswire)--Johnson &amp; Johnson today announced encouraging first-in-human clinical data for an investigational HIV-1 vaccine regimen in development at its Janssen Pharmaceutical Companies. In an oral presentation of the early stage Phase 1/2a APPROACH study at the 9th IAS Conference on HIV Science (IAS 2017), the “mosaic”-based vaccine regimen from Janss...]]></description><pubDate>Mon, 24 Jul 2017 18:05:00 +0900</pubDate></item></channel></rss>